Calendar
A distinguished professional Seminar Series is co-sponsored by
the Institute for Hepatitis and Virus Research, Hepatitis B Foundation,
and the Drexel Institute to promote scientific exchange at a national
and international level. National and international leaders in the
field are invited to speak on a regular schedule.
Seminar Series Schedule 2010
January 28 - 4:00 PM - Joe D'Silva, PhD* (Founder & CEO, Patients' and Consumers' Pharma)
"Designing Pharmaceutical Products for Personalized Medicine"
February 4 - 11:00 AM - Susan Weiss, PhD (University of Pennsylvania School of Medicine)
"Murine Coronavirus CNS Pathogenesis: Host-Virus Interaction"
March 8 - 11:00 AM - Michael Kurilla, MD, PhD* (DMID, NIAID, NIH, DHHS)
"Product Development Resources Through the National Institute of Allergy and Infectious Diseases"
March 10 - 11:00 AM - Robert Perrillo, MD (Baylor University Medical Center)
"Antiviral Therapy of Hepatitis B: Progress and Problems"
March 25 - 11:00 AM - Robert Raffa, PhD** with Scott Rawls, PhD (Temple University School of Medicine)
"Planaria: A Model for Drug Action and Screen for CNS-Active Therapeutics"
April 1 - 4:00 PM - T. Jake Liang, MD (National Institute of Diabetes and Digestive and Kidney Diseases, NIH)
"Choreographing the Tango Between Hepatitis C Virus and Cells by Functional Genomic Screen"
Hepatitis B Foundation's 2010 Bruce Witte Lecturer
April 9 - 4:00 PM - R. Palmer Beasley, MD (University of Texas School of Public Health)
"HBV - The First Zoonosis?"
Hepatitis B Foundation's 2010 Distinguished Scientist
April 15 - 11:00 AM - Claus Fimmel, MD (Loyola University Medical Center)
"Liver Cancer and Golgi Proteins - The Ups and Downs of GP73"
April 19 - 11:00 AM - John S. Lazo, PhD** (University of Pittsburgh)
"How to Target Pennsylvania as the Center for Drug Discovery and Development"
April 21 - TBD - Eiji Miyoshi, PhD (Osaka University Graduate School of Medicine)
"Fucosylation is a Promising Target for Cancer"
April 27 - Edward Griffith* (Product and Educational Services, LLC)
"Management Principles for Scientists and Entrepreneurs"
May 6 - 4:00 PM - Patrick Chaltin, PhD (Katholieke Universiteit Leuven)
"CD3, Stimulating Innovative Small Molecule Drug Discovery"
May 10 - 11:00 AM - Stephen Goff, PhD (Columbia University)
"Innate Defenses and Viral Infections"
May 13 - 11:00 AM - Greg Burdea, PhD** (Rutgers University)
"Avatars, Games and Clouds -- The Future of Therapy, Today"
May 20 - 11:00 AM - Donna Huryn, PhD** (University of Pennsylvania)
"Using Chemistry to Answer Biological Questions: Small Molecule Probes of Tau, Hsp70 and Cathepsins"
May 21 - 11:00 AM - Ralf Bartenschlager, PhD (University Heidelberg)
"New Insights Into Hepatitis C Virus Replication and Persistence"
June 3 - 11:00 AM - Eileen Jaffe, PhD** (Fox Chase Cancer Center)
"Morpheeins - A New Pathway for Drug Discovery"
June 10 - 11:00 AM - Martin Pomper, MD, PhD** (Johns Hopkins Medical Institutions)
"Translational Molecular Imaging"
June 17 - 11:00 AM - Richard Sifers, PhD (Baylor College of Medicine)
""Glycan-Directed Protein Biosynthetic Quality Control in the Secretory Pathway"
June 21 - 11:00 AM - Prof. Chris McGuigan (Welsh School of Pharmacy, Cardiff University)
"New Drug Discovery for Viruses and Cancer"
June 23 - 4:00 PM - Sri Srivastava, PhD* (ClinTech Research, LLC)
"Preclinical Drug Development and Outsourcing Challenges"
July 22 - 11:00 AM - Fred Krebs, PhD (Drexel University College of Medicine)
"Research in Isolation: Working Safely and Effectively in a Biosafety Level 3 Environment"
July 29 - 11:00 AM - Brendan J. Canning, PhD** (Johns Hopkins Asthma and Allergy Center)
"Cough: Novel Therapeutic Strategies For An Unmet Medical Need"
August 12 - 11:00 AM - Jumin Zhou, PhD (The Wistar Institute)
"Understanding the Epigenome Through Specialized DNA Elements"
August 26 - 11:00 AM - Johnny J. He, PhD (Indiana University School of Medicine)
"Host Control of HIV-1 Replication: A Sam68 Story"
August 31 - 11:00 AM - Chen Liu, MD, PhD (University of Florida)
"Induction of Apoptosis for Liver Cancer Therapy"
September 16 - 11:00 AM - Thomas Shenk, PhD (Princeton University)
"Human Cytomegalovirus Replication and Pathogenesis"
Distinguished Speaker Series
September 20 - 11:00 AM - Peter Katsikis, MD, PhD (Drexel University College of Medicine)
"Phosphorothioate Oligomers as Novel HIV Microbicides With Both Anti-Viral and TLR Inhibitory Activity"
October 1 - 8:30 AM - 1:00 PM - Annual Biotech Conference* (Regional Biotech Council)
To Register Please Visit http://www.ihvr.org/rbc/index.htm
October 8 - 11:00 AM - Anna Proietti, MD, PhD (Fundacao Hemominas)
"HTLV Cohort Study in Belo Horizonte, Brazil: 13 Years of Follow-up"
November 4 - 11:00 AM - Todd Margolis, MD, PhD (University of California, San Francisco)
"Establishment of HSV Latent Infection"
November 11 -11:00 AM - Julie Magarian Blander, PhD (Mount Sinai School of Medicine)
"TBA"
December 16 - 11:00 AM - Jianming Hu, MD, PhD (Pennsylvania State University College of Medicine)
"TBA"
January 20, 2011 - 11:00 AM - Lynn Enquist, PhD (Princeton University)
"Infection and Spread of Herpesviruses in the Nervous System"
Distinguished Speaker Series
For More Information:
Institute for Hepatitis and Virus Research
3805 Old Easton Road, Doylestown, PA 18902
Tele: 215.489.4900
Fax 215.489.4920
Email: info@ihvr.org
* = Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)
**= PA Center for Drug Discovery Seminar Speakers
Please note that all Seminars are held at the IHVR and Drexel Institute
located at the PA Biotechnology
Center of Bucks County in Doylestown, PA. Click
here for Travel Directions.
Past Seminar Series
2009
2008
2007 |
